FINANCIALS

ACAD Acadia Pharmaceuticals Inc 1070494

Income Statement
Revenue	acad-20241231	957,797,000
Net Income	acad-20241231	226,451,000
Profit Margin		23.64%

Balance Sheet
Current Assets	938,318,000
Assets	1,187,756,000
Current Liabilities	394,870,000
Liabilities	454,963,000
Equity	732,793,000
Shares Out	165,876,000

Cash Flow Statement
Operating Cash Flow	157,719,000
Investing Cash Flow	-30,538,000

Market Analysis
Market Cap	2,688,849,808
Price	17.24
BVPS	4.42
PB	3.93
EPS	0.18
PE	89.40
PS	0.70
FCF	127,181,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ACAD documents filed with the SEC.

ACAD Filings Clear

View A List of Tickers